Virtus Fund Advisers’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-607
Closed -$64K 2727
2014
Q2
$64K Buy
+607
New +$59.5K ﹤0.01% 1706

Virtus Fund Advisers's FURX Position: Q3 2014 in Review

Virtus Fund Advisers sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 607 shares — an estimated $64K sold.

Virtus Fund Advisers first reported a position in FURX in Q2 2014 and held it in 1 quarter. The position peaked at $64K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Virtus Fund Advisers reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 607 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $64K.
  • Virtus Fund Advisers first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $64K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.